Mar 31, 2022

Amgen Q1 2022 Earnings Report

Amgen's financial results for Q1 2022 were announced, demonstrating revenue growth and progress in key product areas.

Key Takeaways

Amgen reported a 6% increase in total revenues, reaching $6.2 billion, driven by volume growth in key products and contributions from COVID-19 manufacturing collaborations. GAAP EPS decreased by 5% to $2.68, while non-GAAP EPS increased by 15% to $4.25. The company reaffirmed its 2022 total revenue guidance and revised its EPS guidance.

Total revenues increased by 6% to $6.2 billion, driven by a 2% growth in global product sales and increased Other Revenue from COVID-19 manufacturing collaboration.

GAAP EPS decreased 5% to $2.68, while non-GAAP EPS increased 15% to $4.25, driven by increased revenues and lower weighted-average shares outstanding.

GAAP operating income increased 17% to $2.5 billion, and GAAP operating margin increased 5.5 percentage points to 43.6%.

The company generated $2.0 billion of free cash flow, compared to $1.9 billion in the first quarter of 2021.

Total Revenue
$6.24B
Previous year: $5.9B
+5.7%
EPS
$4.25
Previous year: $3.7
+14.9%
Gross Profit
$4.68B
Previous year: $4.41B
+6.0%
Cash and Equivalents
$6.53B
Previous year: $6.11B
+6.8%
Free Cash Flow
$2B
Previous year: $1.9B
+5.3%
Total Assets
$59.2B
Previous year: $62.5B
-5.3%

Amgen

Amgen

Amgen Revenue by Segment

Amgen Revenue by Geographic Location

Forward Guidance

Amgen reaffirmed its 2022 total revenues guidance at $25.4-$26.5 billion and non-GAAP EPS guidance at $17.00-$18.00. The company revised its GAAP EPS guidance to $12.53-$13.58.

Positive Outlook

  • Total revenues are expected to be in the range of $25.4 billion to $26.5 billion.
  • Non-GAAP EPS is expected to be in the range of $17.00 to $18.00.
  • Capital expenditures are anticipated to be approximately $950 million.
  • Share repurchases are planned in the range of $6.0 billion to $7.0 billion.
  • Non-GAAP tax rate is expected to be in the range of 13.5% to 14.5%.

Challenges Ahead

  • GAAP EPS is projected to be in the range of $12.53 to $13.58.
  • GAAP tax rate is expected to be in the range of 10.5% to 12.0%.
  • The company is contesting adjustments and penalties proposed by the IRS for the 2010-15 period, which could result in additional federal tax of approximately $5.1 billion, plus interest, and penalties of approximately $2 billion.
  • The IRS is currently auditing the 2016-2018 period, and the outcome is uncertain.
  • Potential transfer pricing adjustments by the IRS for the 2016-2018 period may be lessened by the change in tax rates resulting from the 2017 tax reform law.

Revenue & Expenses

Visualization of income flow from segment revenue to net income